# Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/combined-therapy-sensitivity-index-based-on-a-13-gene-signature-predicts/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ningrong Ye,Nian Jiang,Cheng-Yuan Feng,Feiyifan Wang,Hanwen Zhang,Harrusin Xiao Bai,Li Yang,Yandong Su,Chunhai Huang,Siyi Wanggou,Xuejun Li |
| Citations | 36 |
| DOI | 10.7150/jca.30614 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.jcancer.org/v10p5536.pdf |
| OpenAlex ID | https://openalex.org/W2972669472 |
| PMID | 31632497 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Hanwen Zhang](https://scholariq.org/researchers/hanwen-zhang/)

## Paper primary topic

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

## Paper topics

- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.